Cargando…

Overexpression of DDX49 in prostate cancer is associated with poor prognosis

BACKGROUND: There is increasing evidence that DEAD-box helicases (DDX) can act either as promoters or suppressors in various cancer types. Nevertheless, the function of DDX49 in prostate cancer (PCa) is unknown. This study reveals the prognostic and predictive value of DDX49 in PCa. METHODS: First,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Junyue, Ge, Qintao, Meng, Jialing, Liang, Chaozhao, Hao, Zongyao, Zhou, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134639/ https://www.ncbi.nlm.nih.gov/pubmed/37106339 http://dx.doi.org/10.1186/s12894-023-01251-4

Ejemplares similares

EPM2A acts as a protective factor in prostate cancer, evidence from a real-world patient cohort
por: Ge, Qintao, et al.
Publicado: (2022)

Molecular classifications of prostate cancer: basis for individualized risk stratification and precision therapy
por: Ge, Qintao, et al.
Publicado: (2023)

Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
por: Yang, Cheng, et al.
Publicado: (2022)

Integrated multi‐omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer
por: Meng, Jialin, et al.
Publicado: (2021)

Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy
por: Meng, Jialin, et al.
Publicado: (2021)

Positive response of a recurrent clear cell sarcoma to anlotinib combined with chemotherapy: A case report
por: Tao, Junyue, et al.
Publicado: (2022)

DDX39 Overexpression Predicts a Poor Prognosis and Promotes Aggressiveness of Melanoma by Cooperating With SNAIL
por: Xing, Chengjuan, et al.
Publicado: (2020)

Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
por: Bian, Zichen, et al.
Publicado: (2022)

hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis
por: Xu, Hanjiang, et al.
Publicado: (2022)

Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
por: Meng, Jialin, et al.
Publicado: (2022)

Associated Factors for Prostate Enlargement in Chinese Adult Men Aged <40 Receiving Checkups
por: Zhang, Xiaoma, et al.
Publicado: (2022)

Lack of Association between Common Polymorphisms in Selenoprotein P Gene and Susceptibility to Colorectal Cancer, Breast Cancer, and Prostate Cancer: A Meta-Analysis
por: Xu, Hanjiang, et al.
Publicado: (2021)

p27-V109G Polymorphism Is Not Associated with the Risk of Prostate Cancer: A Case-Control Study of Han Chinese Men in Central China
por: Zhang, Meng, et al.
Publicado: (2018)

Immune response drives outcomes in prostate cancer: implications for immunotherapy
por: Meng, Jialin, et al.
Publicado: (2020)

Nomogram for predicting the overall survival of patients with early‐onset prostate cancer: A population‐based retrospective study
por: Hu, Yongtao, et al.
Publicado: (2022)

Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour
por: Meng, Jialin, et al.
Publicado: (2022)

In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
por: Zhang, Meng, et al.
Publicado: (2023)

HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2021)

Association Between Twelve Polymorphisms in Five X-ray Repair Cross-complementing Genes and the Risk of Urological Neoplasms: A Systematic Review and Meta-Analysis
por: Zhang, Meng, et al.
Publicado: (2017)

SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis
por: Flockerzi, Fidelis Andrea, et al.
Publicado: (2023)

High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer
por: Dai, Ling, et al.
Publicado: (2018)

DDX49 is a novel biomarker and therapeutic target for lung cancer metastases
por: Lian, Xiaojuan, et al.
Publicado: (2019)

Do polymorphisms in protein kinase catalytic subunit alpha-1 gene associated with cancer susceptibility? a meta-analysis and systematic review
por: Meng, Jialin, et al.
Publicado: (2018)

Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer
por: Zeng, Yan-Ru, et al.
Publicado: (2015)

Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients
por: Tao, Junyue, et al.
Publicado: (2022)

DExD/H Box Helicases DDX24 and DDX49 Inhibit Reactivation of Kaposi’s Sarcoma Associated Herpesvirus by Interacting with Viral mRNAs
por: Serfecz, Jacquelyn C., et al.
Publicado: (2022)

Morphine may act via DDX49 to inhibit hepatocellular carcinoma cell growth
por: Dai, Huijun, et al.
Publicado: (2021)

Comprehensive Review of Genetic Association Studies and Meta-Analysis on polymorphisms in microRNAs and Urological Neoplasms Risk
por: Zhang, Ligang, et al.
Publicado: (2018)

Higher Intake of Fat, Vitamin E-(β+γ), Magnesium, Sodium, and Copper Increases the Susceptibility to Prostatitis-like Symptoms: Evidence from a Chinese Adult Cohort
por: Zhang, Meng, et al.
Publicado: (2022)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
por: Chen, Chaojiang, et al.
Publicado: (2020)

Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
por: Zhang, Meng, et al.
Publicado: (2022)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

Effects of RNA Binding Proteins on the Prognosis and Malignant Progression in Prostate Cancer
por: Hua, Xiaoliang, et al.
Publicado: (2020)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
por: Chen, Yibing, et al.
Publicado: (2018)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

Overexpression of MUC1 predicts poor prognosis in patients with breast cancer
por: Jing, Xuan, et al.
Publicado: (2019)

SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma
por: Chuang, Hao-Wen, et al.
Publicado: (2021)

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer
por: Abdel-Fatah, T M A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q9i23dcsr6tdtag1j7ib5vv2um